39 reports

HIV/ AIDS, rheumatoid arthritis, hepatitis B and psychiatric disorders.

  • Chronic Pain
  • China
  • Demand
  • Bayer AG
  • Yunnan Baiyao Group Co., Ltd.

HIV/ AIDS, rheumatoid arthritis, hepatitis B and psychiatric disorders.

  • Chronic Pain
  • China
  • Bayer AG
  • Novartis AG
  • Pfizer Inc.

THE REPORT FURTHER ESTIMATED THAT ##. ##% OF HEPATITIS B, ##. ##% OF HEPATITIS C AND ##. ##% OF HIV/ AIDS CASES IN HEALTHCARE WORKERS AROUND THE WORLD WERE FOUND TO BE DUE TO NEEDLESTICK INJURIES.

  • Chronic Pain
  • Vaccine
  • United States
  • Demand
  • Market Size

FOR HIV/ AIDS (PHASE III), ZORCELL FOR PSORIASIS (PHASE ## RemuneX™ is a trademark of Immune Response BioPharma ## Zorcell™ is a trademark of Immune Response BioPharma ## CrohnsVax™ is a trademark of Immune Response BioPharma ## ##.

  • Chronic Pain
  • North America
  • United States
  • AbbVie Inc.
  • Astellas Pharma Inc.
  • Chronic neuropathic pain is caused by injury or another disease. Some common causes may include

Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Neuropathic Pain in 15 Major Markets Neuropathic pain is generally defined as chronic pain resulting from injury to the nervous system. Neuropathic pain is caused by other conditions or diseases such as diabetes or herpes zoster infection, and is often accompanied...

  • Chronic Disease
  • Chronic Pain
  • Pathology

The drug candidate is filed for marketing authorization in the Republic of Senegal for HIV/ AIDS, cancer and as an immune booster.

  • Chronic Pain
  • Pharmaceutical
  • Therapy
  • United States
  • Product Initiative

The company' s target therapeutic areas include rheumatoid arthritis, HIV/ AIDS, respiratory infections, cancer, diabetes, men' s and women' s health, and genetic conditions.

  • Chronic Pain
  • North America
  • United States
  • Forecast
  • Thermo Fisher Scientific, Inc.

ELISA is widely used for the diagnosis of HIV/ AIDS (human immunodeficiency virus-acquired immunodeficiency syndrome), owing to the highly-sensitive nature of these assays.

  • Arthritis
  • Chronic Pain
  • World
  • Market Size
  • Thermo Fisher Scientific, Inc.
  • PIPELINE BY IMMUNE RESPONSE BIOPHARMA INC, H2 2017

Its products are used to treat multiple sclerosis, sepsis shock, HIV AIDS, rheumatoid arthritis, Crohns disease and psoriasis.

  • Chronic Pain
  • Hospital
  • Therapy
  • United States
  • Product Initiative

The drug candidate is filed for marketing authorization in the Republic of Senegal for HIV/ AIDS, cancer and as an immune booster.

  • Chronic Pain
  • Therapy
  • United States
  • World
  • Product Initiative
  • DORMANT PRODUCTS, H1 2017 (CONTD..1), H1 2017

Interleukin ## Receptor Type ## (CD## Antigen Like Family Member A or Interleukin ## Receptor Alpha or p## or CD##a or IL##R##) - Pipeline Review, H## 2017 Reference Code: GMDHC##TDB Publication Date: June 2017 LIST OF TABLES Introduction GLOBAL MARKETS DIRECT REPORT COVERAG

  • Chronic Pain
  • Cytokine
  • United States
  • World
  • Product Initiative

Its lead product candidate Syndros (dronabinol oral solution) is intendedfor the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in patients with AIDS.

  • Cancer
  • Chronic Pain
  • United States
  • World
  • Product Initiative

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Chemokine
  • Chronic Pain
  • Hospital
  • Therapy
  • ChemoCentryx, Inc.

The elderly population, individuals that have suffered a Shingles infection, HIV/ AIDS and cancer patients are at highest risk of contracting PHN.

  • Chronic Pain
  • Pharmaceutical
  • United States
  • Company
  • Product Initiative
  • DIABETIC NEUROPATHIC PAIN - PIPELINE BY BRISTOL-MYERS SQUIBB COMPANY, H2 2016
  • BRISTOL-MYERS SQUIBB COMPANY

Diabetic Neuropathic Pain - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Diabetic Neuropathic Pain - Pipeline Review, H2 2016’, provides an overview of the Diabetic Neuropathic Pain pipeline landscape. The report provides comprehensive information on the therapeutics under development for Diabetic...

  • Chronic Pain
  • Therapy
  • United States
  • World
  • Product Initiative
  • Target
  • 5. All the trials included are unique trials.

(Inactive) Neurologic AIDS Research Consortium ## Sep 2003 ## Aug 2003 ## Dec 2004 ## Mar 2005 ## ## ## ## Target Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Molecule(s)

  • Chronic Pain
  • Clinical Trial
  • Neurology
  • World
  • Pfizer Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

(Inactive) Neurologic AIDS Research Consortium ## Sep 2003 ## Aug 2003 ## Dec 2004 ## Mar 2005 ## ## ## ## Official Title Clinical Trial profile. ## Trial Title Official Title Trial Identifier Secondary ID(s) Therapy Area Indication(s) Trial Status Trial Phase Study Type Drug(s)/ Mo

  • Chronic Pain
  • Clinical Trial
  • Drug Discovery And Development
  • Neurology
  • Pfizer Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Boehringer Sohn AG & Co KG ## ## ## ## ## ## ## ## Amgen Inc ## ## ## ## ## ## ## ## Mylan NV ## ## ## ## ## ## ## ## Parexel International Corp ## ## ## ## ## ## ## ## Novartis AG ## ## ## ## ## ## ## ## Johnson & Johnson ## ## ## ## ## ## ## ## Bristol-My

  • Chronic Pain
  • Monoclonal Antibody
  • World
  • Product Initiative
  • Pfizer Inc.

Its product line includes chemicallysynthesized drugs and biological products in the areas of cancer, psychiatric disorders, cardiovascular disorders, diabetes, hepatitis B, HIV/ AIDS and rheumatoid arthritis.

  • Chronic Pain
  • Therapy
  • United States
  • Product Initiative
  • NeurOp, Inc.

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Pfizer Inc.
  • IMMUNE RESPONSE BIOPHARMA INC

Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2018 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Crohn’s Disease (Regional Enteritis) - Pipeline Review, H1 2018, provides an overview of the Crohn’s Disease (Regional Enteritis) (Gastrointestinal)...

  • Chronic Pain
  • Monoclonal Antibody
  • Therapy
  • United States
  • Product Initiative

Its products are used to treat multiple sclerosis, sepsis shock, HIV/ AIDS, rheumatoid arthritis, Crohn' s disease and psoriasis.

  • Arthritis
  • Chronic Pain
  • United States
  • Company
  • Product Initiative

## ## ## ## ## ## India ## ## ## ## ## ## Mexico ## ## ## ## ## ## China ## ## ## ## ## ## Turkey ## ## ## ## ## ## Source: GlobalData' s Pharma eTrack Clinical Trials Database (*)Trials are taken for a time period of 1995 - 2015 2015 t

  • Chronic Pain
  • Musculoskeletal Disorder
  • Pharmaceutical
  • World
  • Product Initiative

Its products are used to treat multiple sclerosis, sepsis shock, HIV AIDS, rheumatoid arthritis, Crohn' s disease and psoriasis.

  • Cell Therapy
  • Chronic Pain
  • Neurological Disorder
  • Pathology
  • Anavex Life Sciences Corp.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Chronic Pain
  • Clinical Trial
  • Drug Discovery And Development
  • World
  • Product Initiative

Its products are used to treat multiple sclerosis, sepsis shock, HIV/ AIDS, rheumatoid arthritis, Crohn' s disease and psoriasis.

  • Arthritis
  • Autoimmune Disease
  • Chronic Pain
  • Research And Development
  • Pfizer Inc.
  • RHEUMATOID ARTHRITIS - PIPELINE BY HETERO DRUGS LTD, H2 2017
  • RHEUMATOID ARTHRITIS - PIPELINE BY HANWHA CHEMICAL CORP, H2 2017

Its products are used to treat multiple sclerosis, sepsis shock, HIV AIDS, rheumatoid arthritis, Crohn' s disease and psoriasis.

  • Arthritis
  • Chronic Pain
  • Pathology
  • Therapy
  • Pfizer Inc.

The prominent features of this report are - ##.

  • Chronic Pain
  • Neurology
  • Therapy
  • World
  • Product Initiative
  • FEATURED NEWS & PRESS RELEASES

The elderly population, individuals that have suffered a Shingles infection, HIV/ AIDS and cancer patients are at highest risk of contracting PHN.

  • Chronic Pain
  • Neurological Disorder
  • United States
  • Company
  • Product Initiative

Its products are used to treat multiple sclerosis, sepsis shock, HIV/ AIDS, rheumatoid arthritis, Crohn' s disease and psoriasis.

  • Cell Therapy
  • Chronic Pain
  • Neurological Disorder
  • Pathology
  • Anavex Life Sciences Corp.